Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia

1744-859X-7-25 1744-859X Primary research Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia Yoshihara Yujiro yoshihar@hama-med.ac.jp Sugihara Genichi genichi@hama-med.ac.jp Matsumoto Hideo mhideo@is.icc.u-tokai.ac.jp Suckling John js369@cam.ac.uk Nishimura Katsuhiko nkatsu2001jp@yahoo.co.jp Toyoda Takao toyoda@hmedc.or.jp Isoda Haruo hisoda@hama-med.ac.jp Tsuchiya J Kenji tsuchiya@hama-med.ac.jp Takebayashi Kiyokazu kiyokazu@hama-med.ac.jp Suzuki Katsuaki k-suzuki@hama-med.ac.jp Sakahara Harumi sakahara@hama-med.ac.jp Nakamura Kazuhiko nakamura@hama-med.ac.jp Mori Norio morin@hama-med.ac.jp Takei Nori ntakei@hama-med.ac.jp

Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Japan

Osaka-Hamamatsu Joint Research Center for Child Mental Development, Hamamatsu, Japan

Department of Psychiatry and Behavioral Sciences, Tokai University School of Medicine, Isehara, Japan

Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK

Department of Radiology, Hamamatsu University School of Medicine, Hamamatsu, Japan

Division of Psychological Medicine, Institute of Psychiatry, King's College, University of London, London, UK

Annals of General Psychiatry 1744-859X 2008 7 1 25 http://www.annals-general-psychiatry.com/content/7/1/25 19102744 10.1186/1744-859X-7-25 04 10 2008 22 12 2008 22 12 2008 2008 Yoshihara et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Investigation into the whole brain morphology of early onset schizophrenia (EOS) to date has been sparse. We studied the regional brain volumes in EOS patients, and the correlations between regional volume measures and symptom severity.

Methods

A total of 18 EOS patients (onset under 16 years) and 18 controls matched for age, gender, parental socioeconomic status, and height were examined. Voxel-based morphometric analysis using the Brain Analysis Morphological Mapping (BAMM) software package was employed to explore alterations of the regional grey (GM) and white matter (WM) volumes in EOS patients. Symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS).

Results

EOS patients had significantly reduced GM volume in the left parahippocampal, inferior frontal, and superior temporal gyri, compared with the controls. They also had less WM volume in the left posterior limb of the internal capsule and the left inferior longitudinal fasciculus. The positive symptom score of PANSS (higher values corresponding to more severe symptoms) was negatively related to GM volume in the bilateral posterior cingulate gyrus. The negative symptom score was positively correlated with GM volume in the right thalamus. As for the association with WM volume, the positive symptom score of PANSS was positively related to cerebellar WM (vermis region), and negatively correlated with WM in the brain stem (pons) and in the bilateral cerebellum (hemisphere region).

Conclusion

Our findings of regional volume alterations of GM and WM in EOS patients coincide with those of previous studies of adult onset schizophrenia patients. However, in brain regions that had no overall structural differences between EOS patients and controls (that is, the bilateral posterior cingulate gyrus, the right thalamus, the cerebellum, and the pons), within-subject analysis of EOS patients alone revealed that there were significant associations of the volume in these areas and the symptom severity. These findings suggest that at an early stage of the illness, especially for those with onset before brain maturation, a wide range of disturbed neural circuits, including these brain regions that show no apparent morphological changes, may contribute to the formation of the symptomatology.

Background

Schizophrenia is a mental disorder with typical onset in early adulthood 1. Although the disorder has also been identified in children and early adolescents, such occurrences are rare 23. Several studies have gathered and scrutinised brain samples from early onset schizophrenia (EOS) patients in various domains. In particular, since brain morphological abnormalities are consistently found in the general samples of patients with schizophrenia (that is, adult onset populations), researchers have focused on the exploration of brain morphology in patients with EOS, defined herein as schizophrenia with onset under age 18 456. Using magnetic resonance imaging (MRI), some research groups have reported enlargement of the lateral ventricles 78, and regional volume reduction in the superior temporal gyrus 910, thalamus 81112, and frontal lobe 121314 in EOS patients, mirroring findings reported in individuals with adult onset schizophrenia (AOS) 151617. However, compared with AOS studies, the number of EOS studies, especially by separate research groups, is still small, and thus studies using an independent sample of EOS patients are in demand.

Previous studies of AOS patients have reported the relationships between structural brain volume alterations, and positive and negative symptoms in various brain regions, such as the superior temporal gyrus 181920, insula 21, fusiform gyrus 20, parahippocampal gyrus 22, basal ganglia 23, and prefrontal gyri 24. As for EOS patients, a few studies have investigated the relationships between regional brain changes and the symptom severity, and the regions found to be related to the symptoms in EOS patients, such as the hippocampal 5, occipital, and parietal cortices 25, are not entirely consistent with the reports on AOS patients.

Brain development in early life is thought to be dynamic, with the patterns of growth being diverse across different brain regions 26. In particular, brain regions that are inherently linked with the pathology of schizophrenia may undergo disproportional changes during the vulnerable period of brain development (that is, the period before adolescence) 2728. In the present study, we conducted voxel-based structural MRI analyses to explore any pattern of regional brain tissue volume abnormalities, and to elucidate the relationships between the regional brain volume and the severity of clinical symptoms in EOS patients.

Methods

Recruitment of participants

Patients who fulfilled Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) 29 criteria for schizophrenia and who had been under the age of 18 years at onset 456 were recruited from among inpatient and outpatient facilities at the Hamamatsu University Hospital and associated hospitals in the city of Hamamatsu, Japan. In all, 18 patients with onset equal to or below 16 years participated in the study. A total of 18 healthy control participants were recruited from the community in Hamamatsu by way of posted advertisement and word of mouth. They were matched to the patients for age, gender, parental socioeconomic status, and height. Participants in both the EOS and control groups were excluded if they had: (1) any current neurological disorders or family history of hereditary neurological disorders, (2) a history of head injury resulting in loss of consciousness, (3) alcohol or substance abuse, or (4) metallic objects in their body (exclusion criterion for MRI). Patients were also excluded if they had any comorbid DSM-IV axis I disorder. The study was approved by the Ethics Committee of the Hamamatsu University School of Medicine. After a complete description of the study to each participant and his or her parents, written informed consent was obtained.

Clinical assessments

Diagnosis was made on the basis of interviews by two trained psychiatrists (one of whom was a child psychiatrist), along with reference to medical records and information from family members and attending physicians. The dose and duration of medication were also recorded. Age at onset of schizophrenia was defined as the age when patients first clearly manifested either delusions, hallucinations, or thought disorders. Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS) 30. Diagnosis was established with the Structured Clinical Interview for DSM-IV (SCID) 31. For those participants under the age of 16, the interview was supplemented by the KID SCID 32. Parental socioeconomic status was determined according to the Standard Occupational Classification 33, and handedness was determined by self-report. Statistical significance was set at p < 0.05 for clinical comparisons, and for the volume measures (two-tailed).

MRI acquisition

All participants were scanned with a GE Signa 1.5-T system (GE Medical Systems, Milwaukee, WI, USA) at the Hamamatsu University School of Medicine. A preliminary localising scan in the coronal plane was used to identify anterior and posterior commissures, and to prescribe acquisition of a dual echo fast spin echo dataset in a plane parallel to the intercommissural line. Contiguous, interleaved proton density- and T2-weighted images, each 3-mm thick, were obtained to provide whole brain coverage. The repetition time (TR) was 4000 ms, and echo times (TE) were 14 and 84 ms with an 8-echo train length. The matrix size was 256 × 192 collected from a rectangular field of view of 24 cm × 18 cm, giving an in-plane resolution of 0.859 mm. The total acquisition time was 9 min 36 s.

Data analysis

Group differences in grey and white matter were assessed using the Brain Analysis Morphological Mapping (BAMM) software package http://www-bmu.psychiatry.cam.ac.uk/software. This process has previously been described in detail for both adult and child populations 233435. Briefly, images were processed to remove extracerebral tissues 36, and then segmented into grey and white matter, cerebrospinal fluid (CSF) and a fourth class including dura, vessels, and other extraneous tissues which were subsequently ignored 37. Global volumes of grey and white matter, CSF, and whole brain (grey and white matter plus CSF) were calculated and compared across groups using independent t tests with the level of significance set at p < 0.05. The segmented images were mapped into the standard space of Talairach and Tournoux 38 by minimising the sum of the square intensity differences between each proton density image and a template and applying the derived mappings to the segmented tissue maps. All maps were smoothed with a Gaussian kernel of 2 mm standard deviation 37. Between-group differences in grey matter volume and white matter volume were estimated by fitting an analysis of covariance (ANCOVA) model at each intracerebral voxel in standard space, which included the age at scan, sex, and whole brain volume as covariates. Maps of the appropriate normalised coefficient were subject to an inference procedure in which the significance of a three-dimensional cluster statistic was assessed using non-parametric methods 39. The statistical thresholds were corrected for multiple comparisons by controlling the 'family-wise error rate', in this case by setting the p value used such that < 1 false-positive cluster was expected under the null hypothesis 39. A cluster of grey or white matter abnormality was defined as a deficit or an excess depending on whether the volume was reduced or increased in the EOS group relative to the control group. Within the patient group, the relationships between grey and white matter volume and positive, negative and global score (PANSS) were estimated by fitting a regression model at each intracerebral voxel in standard space for each tissue class separately.

When the assumptions of the parametric methods are not guaranteed, the non-parametric methods provide the only analysis that can be considered valid and exact. As the distribution of the structural data derived from MRI scans may violate the assumptions, such as normal distribution, we thus employed non-parametric methods in this study.

Results

Demographic and clinical characteristics

The EOS and healthy control groups were similar as regards the distribution of age, sex, ethnicity, social class, and height (Table 1). All participants were right-handed. Healthy controls had a significantly (p < 0.001) higher mean IQ than the patients. In all, 17 EOS patients had received antipsychotic medication, and 1 EOS patient had never received antipsychotic medication.

Table 1

Subject characteristics

Variable

Healthy controls

(n = 18)

EOS patients

(n = 18)

p Value

Age (years)^a

15.8 (1.3)

15.8 (1.8)

0.693

Sex (male/female)^b

9/9

1.00

Social class 1–3^b

16 (89%)

14 (78%)

0.371

Height (cm)^a

163.6 (7.1)

158.8 (8.6)

0.085

IQ^a

97.3 (11.8)

72.8 (15.3)

0.001

Duration of illness (years)

1.2 (0.9)

Positive and Negative Syndrome Scale:

Positive score

13.8 (4.4)

Negative score

19.1 (10.0)

Global score

31.1 (10.7)

Values are given as the mean (SD), except for sex and social class.

^aTwo-tailed t test; ^bχ²test.

EOS, early onset schizophrenia; SD, standard deviation.

Brain and CSF volumetric measures

Global volumes for the whole brain and each of the three main tissue classes (grey matter, white matter, and CSF) are shown in Table 2. In the EOS group, grey matter (GM) volume was 5.5% smaller and white matter (WM) volume was 3.9% smaller than in the control group, whereas CSF volume in the EOS group was 11.5% larger than in the control group. The differences in GM and CSF between the two groups were significant (p < 0.032 and 0.008, respectively), but the difference in WM was not (p < 0.12). In addition, EOS patients had a significantly (4.0%; p < 0.009) smaller GM to whole brain ratio and significantly (15.4%; p < 0.001) larger CSF to whole brain ratio compared with the controls.

Table 2

Global brain volumes

Global brain volumes

Control group ^a

(n = 18)

EOS group ^a

(n = 18)

Group difference

(%)

p Value

Whole brain (ml)

1,325.7 (106.4)

1,290.0 (47.4)

2.7 (Control > EOS)

1.302

0.205

Grey matter (ml)

657.2 (60.4)

621.3 (29.5)

5.5 (Control > EOS)

2.271

0.032

White matter (ml)

496.5 (46.9)

476.9 (19.7)

3.9 (Control > EOS)

1.638

0.115

CSF (ml)

172.0 (20.3)

191.8 (21.9)

11.5 (EOS > Control)

-2.813

0.008

Grey matter/whole brain ratio

0.50 (0.01)

0.48 (0.02)

4.0 (Control > EOS)

2.814

0.009

White matter/whole brain ratio

0.37 (0.01)

1.314

0.199

CSF/whole brain ratio

0.13 (0.02)

0.15 (0.01)

15.4 (EOS > Control)

-3.507

0.001

^aValues are given as the mean (SD).

CSF, cerebrospinal fluid; EOS, early onset schizophrenia; SD, standard deviation.

Regional grey matter (GM) and white matter (WM) alterations in EOS patients

The EOS group had a significantly smaller GM in the left parahippocampal gyrus (Brodmann's area: 34), the left inferior frontal gyrus (Brodmann's area: 47), and the left superior temporal gyrus (Brodmann's area: 22), compared with the control group (Figure 1, Table 3). The EOS group also had significantly less WM in the left posterior limb of the internal capsule, and the left inferior longitudinal fasciculus (Figure 2, Table 3).

Table 3

Grey and white matter regional differences between early onset schizophrenia (EOS) group and control group

Area

Brodmann area

Talairach coordinate of centroid voxel (mm)

Number of voxels in cluster

Control > EOS in grey matter:

Left parahippocampal gyrus,

34/47/22

-57

-4

423

Left inferior frontal gyrus,

Left superior temporal gyrus

Control > EOS in white matter:

Left posterior limb of internal capsule

-20

-8

418

Left inferior longitudinal fasciculus

Figure 1

Grey matter regional differences between early onset schizophrenia group (n = 18) and control group (n = 18)

Grey matter regional differences between early onset schizophrenia group (n = 18) and control group (n = 18). Blue regions denote areas of grey matter deficits in the early onset schizophrenia group relative to the control group. The left side of the figure represents the right side of the brain; the z coordinate for each axial slice in the standard space of Talairach and Tournoux 38 is given in mm. Cluster-wise probability of type I error: p = 0.001, with less than one false-positive cluster expected over the whole map.

Figure 2

White matter regional differences between early onset schizophrenia group (n = 18) and control group (n = 18)

White matter regional differences between early onset schizophrenia group (n = 18) and control group (n = 18). Blue regions denote areas of white matter deficits in the early onset schizophrenia group relative to the control group. The left side of the figure represents the right side of the brain; the z coordinate for each axial slice in the standard space of Talairach and Tournoux 38 is given in mm. Cluster-wise probability of type I error: p = 0.001, with less than one false-positive test expected over the whole map.

Association between symptoms and volumetric measures (GM and WM) in EOS patients

The positive symptom score of PANSS (with higher values in the PANSS corresponding to more severe symptoms) was negatively related to GM volume in the bilateral posterior cingulate gyrus (Figure 3, Table 4). The negative symptom score was positively correlated with GM volume in the right thalamus (Figure 4, Table 4). As for the association with WM volume, the positive symptom score of PANSS was positively related to cerebellar WM (vermis region), and negatively correlated with WM in the brain stem (pons) and in the bilateral cerebellum (hemisphere region) (Figure 5, Table 4). We found no significant association between regional WM volume change and the negative symptom score of PANSS.

Table 4

Association between positive/negative syndrome scores and grey and white matter tissue class volume in patients with early onset schizophrenia (n = 18)

Tissue class and relative difference region

Talairach coordinate of centroid voxel (mm)

Number of voxels in cluster

Grey matter:

Positive symptom

Negative correlation

Bilateral posterior cingulate gyrus

-55

256

Negative symptom

Positive correlation

Right thalamus

-14

224

White matter:

Positive symptom

Positive correlation

Cerebellum (vermis)

-48

-12

1,370

Negative correlation

Brain stem (pons)

-3

-21

-24

921

Cerebellum (hemisphere)

Figure 3

Association between positive syndrome scores and grey matter tissue class volume in patients with early onset schizophrenia (n = 18)

Association between positive syndrome scores and grey matter tissue class volume in patients with early onset schizophrenia (n = 18). Blue regions denote areas in which lower grey matter volume is predicted by a higher score on a positive symptom rating scale in the early onset schizophrenia group. The left side of the figure represents the right side of the brain; the z coordinate for each axial slice in the standard space of Talairach and Tournoux 38 is given in mm. Cluster-wise probability of type I error: p = 0.001, with less than one false-positive test expected over the whole map.

Figure 4

Association between negative syndrome scores and grey matter tissue class volume in patients with early onset schizophrenia (n = 18)

Association between negative syndrome scores and grey matter tissue class volume in patients with early onset schizophrenia (n = 18). Red regions denote areas in which larger grey matter volume is predicted by a high score on a negative symptom rating scale in the early onset schizophrenia group. The left side of the figure represents the right side of the brain; the z coordinate for each axial slice in the standard space of Talairach and Tournoux 38 is given in mm. Cluster-wise probability of type I error: p = 0.001, with less than one false-positive test expected over the whole map.

Figure 5

Association between positive/negative syndrome scores and white matter tissue class volume in patients with early onset schizophrenia (n = 18)

Association between positive/negative syndrome scores and white matter tissue class volume in patients with early onset schizophrenia (n = 18). Red regions denote areas in which larger white matter volume is predicted by a higher score on a positive symptom rating scale in the early onset schizophrenia group. Blue regions denote areas in which lower white matter volume is predicted by a higher score on a positive symptom rating scale in the early onset schizophrenia group. The left side of the figure represents the right side of the brain; the z coordinate for each axial slice in the standard space of Talairach and Tournoux 38 is given in mm. Cluster-wise probability of type I error: p = 0.001, with less than one false-positive test expected over the whole map.

Discussion

To our knowledge, this is the first voxel-based morphometry study indicating significant relationships between regional brain volume alterations and clinical symptoms in EOS patients (that is, with onset under 16 years). We found a significant GM volume reduction and a significant increase of CSF in EOS patients. The EOS patients had a significant reduction of regional GM in the left parahippocampal gyrus, the left inferior frontal gyrus, and the left superior temporal gyrus. In addition, they had reduced regional WM in the left posterior limb of the internal capsule, and in the left inferior longitudinal fasciculus. When the correlations between regional GM volume and positive symptoms were examined within the EOS patient group, positive symptoms were found to be significantly correlated with the reduced GM volume in the bilateral posterior cingulate gyrus, with the increased WM volume in the cerebellum (vermis region), and with the reduced WM volume in the brain stem and the bilateral cerebellum (hemisphere region). We also found a relationship between the severity of negative symptoms and the increased GM volume in the right thalamus.

The findings of a GM volume reduction and CSF increase in individuals with EOS in this study are compatible with previous volumetric studies of both EOS and adult onset schizophrenia (AOS) patients 71328404142, suggesting that the pattern of volumetric alterations (that is, GM volume reduction and CSF increase) may be an inherent feature of schizophrenia irrespective of age at onset. The GM volume reduction in schizophrenia as a whole could reflect an exaggeration of a normal maturational process of synaptic/dendritic pruning during adolescence 28.

The voxel-based analysis revealed that in the EOS group, the regional volume reduction of GM was evident in the left parahippocampal gyrus, the left inferior frontal gyrus, and the left superior temporal gyrus. These findings were consistent with those of the previous studies in patients with AOS 15434445. However, because regional grey matter alterations have frequently been observed in various brain regions of AOS patients, rather than being limited to these three brain regions alone 15, and because grey matter abnormalities are deemed to be a fundamental part of the pathophysiology of schizophrenia, the observation of grey matter changes in these three regions (that is, the parahippocampal, inferior frontal, and superior temporal gyrus) in individuals with EOS in the present study may indicate that the disease originates in these areas. Another possible explanation is that these three regions may be more subject to brain insults that are related to the predisposition to schizophrenia.

We also found white matter morphological changes in EOS patients. The reduction of WM volume was located in the left posterior limb of the internal capsule, and the left inferior longitudinal fasciculus. Although no prior study has addressed the regional WM volume alterations in EOS, the current findings are similar to those reported by Sigmundsson et al. 23, who investigated WM volume changes in AOS patients. In addition, diffusion tensor imaging (DTI) studies of AOS 46 and EOS 47 patients have also shown WM abnormalities in similar regions. Therefore, there is evidence emerging from a variety of sources to suggest that WM abnormalities are part of the patterns of brain parenchymal aberration associated with schizophrenia, although they may be a secondary process. In addition, we found a relationship between the brain stem (pons) volume reduction and positive symptoms. This may be intriguing in view of the evidence, from a positron emission tomography (PET) study, showing dysregulation of dopaminergic transmission in the midbrain in schizophrenia 48.

In our sample of EOS patients, the brain region that was found to be associated with the severity of the positive symptoms was the posterior cingulate gyrus. Although similar findings have been reported in AOS patients 49, most AOS studies have shown an association with other brain regions, such as the superior temporal gyrus 181920, insula 21, fusiform gyrus 20, and parahippocampal gyrus 22. It is of note, however, that the region of the posterior cingulate gyrus has also been reported to be associated with the positive symptoms in other neuroimaging studies of patients with AOS, such as pharmacological functional MRI 50 and positron emission tomography (PET) studies 51. Furthermore, additional evidence from some AOS studies that the posterior cingulate gyrus volume reduction is associated with other clinical features, such as poor clinical outcome 52, and the lack of insight and judgment 53, suggests that neural circuits involving the posterior cingulate gyrus may have an important role in the pathophysiology of schizophrenia. Given that the posterior cingulate is related to processing of emotionally salient stimuli and spatial attention 54, our finding that the posterior cingulate gyrus became prominent in relation to positive symptoms suggests that this region may be involved in the formation of delusions in individuals with a very early age of onset and at an early stage of the illness.

In the present study, the severity of the positive symptoms of schizophrenia was found to be associated with increased WM volume in the cerebellum (vermis region) and with decreased WM volume in the cerebellum (hemisphere region). The finding in the cerebellar vermis region is consistent with that of a previous AOS study 55 showing a positive correlation between vermis WM volume and the severity of positive symptoms. As regards the cerebellar hemisphere region, neither previous studies employing EOS patients nor those with AOS patients have reported significant correlations with positive symptoms. This is the first study, to our knowledge, to demonstrate a relationship between positive symptoms and a decreased WM volume of the cerebellar hemisphere region.

The severity of the negative symptoms was found to be associated with the increased GM volume of the right thalamus. This finding is similar to the results of prior AOS studies showing a positive correlation between thalamic volume and the severity of negative symptoms 565758. The thalamus is thought to play a role in sensory gating, a disruption of which has been reported to be involved in schizophrenia 5960. Previous AOS studies have also reported correlations between the negative symptoms and structural alterations in other brain regions: namely, reduced volume in the fusiform gyrus 19, frontal lobe WM 246162, prefrontal GM 63, cingulate WM and internal capsule 64, and increased volume in the posterior superior temporal gyrus 65. However, in our sample of EOS patients, there were no associations between morphological measures in any of these regions and the severity score of negative symptoms. It could be that at an early stage of brain development (that is, in adolescence), the thalamus, which has reciprocal connectivity with the frontal regions, may be predominantly involved in generating negative symptoms (that is, cognitive deficits) via disturbed connectivity.

A question may arise as to why no relationships were evident between the clinical symptoms and the morphological measures in the three main brain regions (the frontal, temporal, and parahippocampal gyri) showing significant volume reductions in our EOS patients. What is puzzling is that other regions (that is, the posterior cingulate gyrus and the thalamus) were found to be associated with the symptoms in this study. One possible interpretation is that disturbed neural circuits rather than structural alterations per se may play a role in the formation of symptoms in early onset schizophrenia patients (that is, patients with onset prior to brain maturation). Impaired circuits may involve interconnections between the posterior cingulate gyrus and the temporal lobe 66 and between the thalamus and frontal lobe 6768.

The results of this study should be interpreted in the context of the following limitations. First, the number of subjects was relatively small. In spite of this, the fact that we were able to detect the regional brain volume alterations in a unique sample of patients with EOS and the finding that most of the abnormalities found were identical to those for the general population of adult onset schizophrenia patients, may support the robustness of the current findings. Second, IQ score was not matched between the case and control groups; that is, the mean IQ was significantly lower in the patients than in the controls. Thus, we conducted an additional analysis in which IQ was adjusted for as a covariate, and found that the regional brain volume differences (for example, the three main GM regions) between the groups remained significant. As a result, the effects of IQ on the findings can be taken as minimal, especially with respect to the regional brain changes. Third, the effect of medication was not considered when regional brain changes were compared between the case and control groups. Antipsychotic medication can affect regional brain morphology in schizophrenia, particularly in the thalamus 69 and basal ganglia 70, resulting in increased volumes in these regions. If physicians tended to administer greater dosages of antipsychotic medication to combat the negative symptoms, then the relationship between increased volume in the thalamus and the negative symptoms found in this study would be accounted for by the medication effect. We performed an analysis in which medication dose was entered as a covariate, and found that the correlation between the severity of negative symptoms and the increase of volume in the thalamus remained significant.

Pathophysiological changes in schizophrenia – including brain morphological changes – may be drastic, especially in schizophrenic patients with onset before brain maturation. Therefore, studying schizophrenia patients whose age of onset is as early as childhood is valuable in clarifying the pathophysiological dynamics of the disorder. Large-scale longitudinal studies are also needed to elucidate brain morphological changes in young populations with early onset schizophrenia.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

YY, GS, and TT designed the study. YY and TT contributed to recruitment of study subjects and MRI data collection. HM and TT were involved in clinical evaluation of the participants and procedures of the MRI data acquisition. JS provided assistance of the MRI data collection and performed data analyses. KNi, HI, KJT, KT, KS, HS, KNa and NM participated in the stage of designing the study and recruitment of the study subjects. NT supervised the study and refined the analyses. YY, GS, and NT wrote the manuscript. All the authors read the paper and approved the final form of the manuscript.

Acknowledgements

NT is a recipient of a Grant-in-Aid for Scientific Research (B) (2) (No. 14370288) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.

The influence of age and sex on the onset and early course of schizophrenia Hafner H Maurer K Loffler W Riecher-Rossler A Br J Psychiatry 1993 162 80 86 10.1192/bjp.162.1.80 8425144 Childhood-onset schizophrenia: editors' introduction Asarnow RF Asarnow JR Schizophr Bull 1994 20 591 597 7701270 Childhood-onset schizophrenia: a followup study Asarnow JR Tompson MC Goldstein MJ Schizophr Bull 1994 20 599 617 7701271 Normal cerebral volume asymmetries in early onset schizophrenia Hadjulis M Pipe R Frangou S Biol Psychiatry 2004 55 148 153 10.1016/S0006-3223(02)01905-4 14732594 Structural magnetic imaging of the hippocampus in early onset schizophrenia Matsumoto H Simmons A Williams S Pipe R Murray R Frangou S Biol Psychiatry 2001 49 824 831 10.1016/S0006-3223(01)01073-3 11343679 Enlargement of the fornix in early-onset schizophrenia: a quantitative MRI study Davies DC Wardell AM Woolsey R James AC Neurosci Lett 2001 301 163 166 10.1016/S0304-3940(01)01637-8 11257423 Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images Sowell ER Levitt J Thompson PM Holmes CJ Blanton RE Kornsand DS Caplan R McCracken J Asarnow R Toga AW Am J Psychiatry 2000 157 1475 1484 10.1176/appi.ajp.157.9.1475 10964865 Childhood-onset psychotic disorders: magnetic resonance imaging of volumetric differences in brain structure Kumra S Giedd JN Vaituzis AC Jacobsen LK McKenna K Bedwell J Hamburger S Nelson JE Lenane M Rapoport JL Am J Psychiatry 2000 157 1467 1474 10.1176/appi.ajp.157.9.1467 10964864 Superior temporal gyrus abnormalities in early-onset schizophrenia: similarities and differences with adult-onset schizophrenia Matsumoto H Simmons A Williams S Hadjulis M Pipe R Murray R Frangou S Am J Psychiatry 2001 158 1299 1304 10.1176/appi.ajp.158.8.1299 11481166 Progressive reduction of temporal lobe structures in childhood-onset schizophrenia Jacobsen LK Giedd JN Castellanos FX Vaituzis AC Hamburger SD Kumra S Lenane MC Rapoport JL Am J Psychiatry 1998 155 678 685 9585721 Brain anatomical magnetic resonance imaging in childhood-onset schizophrenia Frazier JA Giedd JN Hamburger SD Albus KE Kaysen D Vaituzis AC Rajapakse JC Lenane MC McKenna K Jacobsen LK Gordon CT Breier A Rapoport JL Arch Gen Psychiatry 1996 53 617 624 8660128 Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia James AC James S Smith DM Javaloyes A Am J Psychiatry 2004 161 1023 1029 10.1176/appi.ajp.161.6.1023 15169690 Structural neuroimaging in adolescents with a first psychotic episode Moreno D Burdalo M Reig S Parellada M Zabala A Desco M Baca-Baldomero E Arango C J Am Acad Child Adolesc Psychiatry 2005 44 1151 1157 10.1097/01.chi.0000179055.46795.3f 16239864 Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses Gogtay N Sporn A Clasen LS Nugent TF 3rd Greenstein D Nicolson R Giedd JN Lenane M Gochman P Evans A Rapoport JL Arch Gen Psychiatry 2004 61 17 22 10.1001/archpsyc.61.1.17 14706940 Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies Honea R Crow TJ Passingham D Mackay CE Am J Psychiatry 2005 162 2233 2245 10.1176/appi.ajp.162.12.2233 16330585 A review of MRI findings in schizophrenia Shenton ME Dickey CC Frumin M McCarley RW Schizophr Res 2001 49 1 52 10.1016/S0920-9964(01)00163-3 11343862 Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies Vita A De Peri L Silenzi C Dieci M Schizophr Res 2006 82 75 88 10.1016/j.schres.2005.11.004 16377156 Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia Barta PE Pearlson GD Powers RE Richards SS Tune LE Am J Psychiatry 1990 147 1457 1462 2221156 Dissociable contributions of MRI volume reductions of superior temporal and fusiform gyri to symptoms and neuropsychology in schizophrenia Nestor PG Onitsuka T Gurrera RJ Niznikiewicz M Frumin M Shenton ME McCarley RW Schizophr Res 2007 91 103 106 10.1016/j.schres.2006.11.025 17229550 Brain structural changes in schizophrenia patients with persistent hallucinations O'Daly OG Frangou S Chitnis X Shergill SS Psychiatry Res 2007 156 15 21 10.1016/j.pscychresns.2007.03.001 17720459 Insular volumes in first-episode schizophrenia: gender effect Duggal HS Muddasani S Keshavan MS Schizophr Res 2005 73 113 120 10.1016/j.schres.2004.08.027 15567083 Parahippocampal gyrus in first episode psychotic disorders: a structural magnetic resonance imaging study Prasad KM Rohm BR Keshavan MS Prog Neuropsychopharmacol Biol Psychiatry 2004 28 651 658 10.1016/j.pnpbp.2004.01.017 15276690 Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms Sigmundsson T Suckling J Maier M Williams S Bullmore E Greenwood K Fukuda R Ron M Toone B Am J Psychiatry 2001 158 234 243 10.1176/appi.ajp.158.2.234 11156806 Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms Sanfilipo M Lafargue T Rusinek H Arena L Loneragan C Lautin A Feiner D Rotrosen J Wolkin A Arch Gen Psychiatry 2000 57 471 480 10.1001/archpsyc.57.5.471 10807487 Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia Vidal CN Rapoport JL Hayashi KM Geaga JA Sui Y McLemore LE Alaghband Y Giedd JN Gochman P Blumenthal J Gogtay N Nicolson R Toga AW Thompson PM Arch Gen Psychiatry 2006 63 25 34 10.1001/archpsyc.63.1.25 16389194 Mapping brain maturation Toga AW Thompson PM Sowell ER Trends Neurosci 2006 29 148 159 10.1016/j.tins.2006.01.007 16472876 Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia Thompson PM Vidal C Giedd JN Gochman P Blumenthal J Nicolson R Toga AW Rapoport JL Proc Natl Acad Sci USA 2001 98 11650 11655 58784 11573002 10.1073/pnas.201243998 Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia Gogtay N Schizophr Bull 2008 34 30 36 10.1093/schbul/sbm103 17906336 American Psychiatric Association Task Force on DSM-IV Diagnostic and statistical manual of mental disorders: DSM-IV Washington, DC: American Pyschiatric Association 4 1994 The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation Kay SR Opler LA Lindenmayer JP Br J Psychiatry Suppl 1989 7 59 67 2619982 First M Spitzer R Gibbon M Williams J Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition New York, NY: New York State Psychiatric Institute 1997 Preliminary test-reset reliability of the KID-SCID Matzner FSR Silvan M Chowdhury M Nastasi L Scientific Proceedings of the 44th Meeting of the American Academy of Child and Adolescent Psychiatry Washington, DC: AACAP 1997 172 173 Office of Population Censuses and Surveys Standard occupational classification, Social classifications and coding methodology London, UK: HMSO 1991 3 Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network Overmeyer S Bullmore ET Suckling J Simmons A Williams SC Santosh PJ Taylor E Psychol Med 2001 31 1425 1435 10.1017/S0033291701004706 11722157 Brain anatomy and sensorimotor gating in Asperger's syndrome McAlonan GM Daly E Kumari V Critchley HD van Amelsvoort T Suckling J Simmons A Sigmundsson T Greenwood K Russell A Schmitz N Happe F Howlin P Murphy DG Brain 2002 125 1594 1606 10.1093/brain/awf150 12077008 Removal of extracerebral tissues in dual-echo magnetic resonance images via linear scale-space features Suckling J Brammer MJ Lingford-Hughes A Bullmore ET Magn Reson Imaging 1999 17 247 256 10.1016/S0730-725X(98)00099-X 10215480 A modified fuzzy clustering algorithm for operator independent brain tissue classification of dual echo MR images Suckling J Sigmundsson T Greenwood K Bullmore ET Magn Reson Imaging 1999 17 1065 1076 10.1016/S0730-725X(99)00055-7 10463658 Talairach J Tournoux P Co-Planar Stereotaxic Atlas of the Human Brain: An Approach to Medical Cerebral Imaging Stuttgart, Germany: Thieme Medical Publishers 1988 Permutation tests for factorially designed neuroimaging experiments Suckling J Bullmore E Hum Brain Mapp 2004 22 193 205 10.1002/hbm.20027 15195286 Meta-analysis of the time-course of brain volume reduction in schizophrenia: implications for pathogenesis and early treatment Woods BT Ward KE Johnson EH Schizophr Res 2005 73 221 228 10.1016/j.schres.2004.05.014 15653264 Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities Davatzikos C Shen D Gur RC Wu X Liu D Fan Y Hughett P Turetsky BI Gur RE Arch Gen Psychiatry 2005 62 1218 1227 10.1001/archpsyc.62.11.1218 16275809 Progression of brain volume changes in adolescent-onset psychosis Reig S Moreno C Moreno D Burdalo M Janssen J Parellada M Zabala A Desco M Arango C Schizophr Bull 2008 doi:10.1093/schbul/sbm160 18222929 Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study Wilke M Kaufmann C Grabner A Putz B Wetter TC Auer DP Neuroimage 2001 13 814 824 10.1006/nimg.2001.0751 11304078 Mapping of grey matter changes in schizophrenia Wright IC Ellison ZR Sharma T Friston KJ Murray RM McGuire PK Schizophr Res 1999 35 1 14 10.1016/S0920-9964(98)00094-2 9988836 Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study Yamasue H Iwanami A Hirayasu Y Yamada H Abe O Kuroki N Fukuda R Tsujii K Aoki S Ohtomo K Kato N Kasai K Psychiatry Res 2004 131 195 207 10.1016/j.pscychresns.2004.05.004 15465289 Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey Mitelman SA Torosjan Y Newmark RE Schneiderman JS Chu KW Brickman AM Haznedar MM Hazlett EA Tang CY Shihabuddin L Buchsbaum MS Schizophr Res 2007 92 211 224 10.1016/j.schres.2006.12.029 17329081 Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography Ashtari M Cottone J Ardekani BA Cervellione K Szeszko PR Wu J Chen S Kumra S Arch Gen Psychiatry 2007 64 1270 1280 10.1001/archpsyc.64.11.1270 17984396 Midbrain dopamine D2/3 receptor binding in schizophrenia Tuppurainen H Kuikka JT Laakso MP Viinamaki H Husso M Tiihonen J Eur Arch Psychiatry Clin Neurosci 2006 256 382 387 10.1007/s00406-006-0649-3 16783502 Morphological brain changes associated with Schneider's first-rank symptoms in schizophrenia: a MRI study Suzuki M Zhou SY Hagino H Niu L Takahashi T Kawasaki Y Matsui M Seto H Ono T Kurachi M Psychol Med 2005 35 549 560 10.1017/S0033291704003885 15856725 NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI Northoff G Richter A Bermpohl F Grimm S Martin E Marcar VL Wahl C Hell D Boeker H Schizophr Res 2005 72 235 248 10.1016/j.schres.2004.04.009 15560968 Cerebral blood flow changes associated with Schneiderian first-rank symptoms in schizophrenia Franck N O'Leary DS Flaum M Hichwa RD Andreasen NC J Neuropsychiatry Clin Neurosci 2002 14 277 282 12154151 Volume of the cingulate and outcome in schizophrenia Mitelman SA Shihabuddin L Brickman AM Hazlett EA Buchsbaum MS Schizophr Res 2005 72 91 108 10.1016/j.schres.2004.02.011 15560955 Gray matter abnormalities in paranoid schizophrenia and their clinical correlations Ha TH Youn T Ha KS Rho KS Lee JM Kim IY Kim SI Kwon JS Psychiatry Res 2004 132 251 260 10.1016/j.pscychresns.2004.05.001 15664796 The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain Maddock RJ Trends Neurosci 1999 22 310 316 10.1016/S0166-2236(98)01374-5 10370255 Quantitative volumetric MRI study of the cerebellum and vermis in schizophrenia: clinical and cognitive correlates Levitt JJ McCarley RW Nestor PG Petrescu C Donnino R Hirayasu Y Kikinis R Jolesz FA Shenton ME Am J Psychiatry 1999 156 1105 1107 10401463 Reduced thalamic volume in first-episode non-affective psychosis: correlations with clinical variables, symptomatology and cognitive functioning Crespo-Facorro B Roiz-Santianez R Pelayo-Teran JM Rodriguez-Sanchez JM Perez-Iglesias R Gonzalez-Blanch C Tordesillas-Gutierrez D Gonzalez-Mandly A Diez C Magnotta VA Andreasen NC Vázquez-Barquero JL Neuroimage 2007 35 1613 1623 10.1016/j.neuroimage.2007.01.048 17395492 Thalamic volume in first-episode and chronic schizophrenic subjects: a volumetric MRI study Preuss UW Zetzsche T Jager M Groll C Frodl T Bottlender R Leinsinger G Hegerl U Hahn K Moller HJ Meisenzahl EM Schizophr Res 2005 73 91 101 10.1016/j.schres.2004.09.019 15567081 Thalamus size and outcome in schizophrenia Brickman AM Buchsbaum MS Shihabuddin L Byne W Newmark RE Brand J Ahmed S Mitelman SA Hazlett EA Schizophr Res 2004 71 473 484 10.1016/j.schres.2004.03.011 15474918 Cortical development and thalamic pathology in schizophrenia Jones EG Schizophr Bull 1997 23 483 501 9327511 Increased hemodynamic response in the hippocampus, thalamus and prefrontal cortex during abnormal sensory gating in schizophrenia Tregellas JR Davalos DB Rojas DC Waldo MC Gibson L Wylie K Du YP Freedman R Schizophr Res 2007 92 262 272 10.1016/j.schres.2006.12.033 17336502 Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia Ho BC Andreasen NC Nopoulos P Arndt S Magnotta V Flaum M Arch Gen Psychiatry 2003 60 585 594 10.1001/archpsyc.60.6.585 12796222 Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study Wible CG Anderson J Shenton ME Kricun A Hirayasu Y Tanaka S Levitt JJ O'Donnell BF Kikinis R Jolesz FA McCarley RW Psychiatry Res 2001 108 65 78 10.1016/S0925-4927(01)00109-3 11738541 Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study Mathalon DH Sullivan EV Lim KO Pfefferbaum A Arch Gen Psychiatry 2001 58 148 157 10.1001/archpsyc.58.2.148 11177116 Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia Paillere-Martinot M Caclin A Artiges E Poline JB Joliot M Mallet L Recasens C Attar-Levy D Martinot JL Schizophr Res 2001 50 19 26 10.1016/S0920-9964(00)00137-7 11378311 Morphology of the lateral superior temporal gyrus in neuroleptic naive patients with schizophrenia: relationship to symptoms Kim JJ Crespo-Facorro B Andreasen NC O'Leary DS Magnotta V Nopoulos P Schizophr Res 2003 60 173 181 12591581 Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study Kubicki M Westin CF Nestor PG Wible CG Frumin M Maier SE Kikinis R Jolesz FA McCarley RW Shenton ME Biol Psychiatry 2003 54 1171 1180 10.1016/S0006-3223(03)00419-0 14643084 Morphometric characterization of synapses in the primate prefrontal cortex formed by afferents from the mediodorsal thalamic nucleus Negyessy L Goldman-Rakic PS Exp Brain Res 2005 164 148 154 10.1007/s00221-005-2237-6 15776222 The primate mediodorsal (MD) nucleus and its projection to the frontal lobe Goldman-Rakic PS Porrino LJ J Comp Neurol 1985 242 535 560 10.1002/cne.902420406 2418080 Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia Gur RE Maany V Mozley PD Swanson C Bilker W Gur RC Am J Psychiatry 1998 155 1711 1717 9842780 Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics Corson PW Nopoulos P Miller DD Arndt S Andreasen NC Am J Psychiatry 1999 156 1200 1204 10450260